Mankind Pharma IPO opened for subscription on 25 April and the issue has been fully subscribed at 15.32 times on day 3. Qualified institutional buyers (QIBs) subscribed for 49.16% of their reserved portion, demonstrating high interest in the issue. The portion for retail investors remains undersubscribed as investors bid only 0.92 times of the shares […]
